Analyst Ratings for Osiris Therapeutics (OSIR)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/17/2015 | Brean Capital | N/A | Downgrade | Sell (Hold) |
8.00 (N/A) |
13.98 (18.99) |
35.84% | Details |
| 9/16/2014 | R.F. Lafferty | N/A | New Coverage | Buy (N/A) |
19.00 (N/A) |
12.73 (18.99) |
49.18% | Details |
 |
||||||||
|
||||||||
